©) Fisher scientific Material Safety Data Sheet Lithium bromide MSDS# 00857 Section 1 - Chemical Product and Company Identification MSDS Name: Lithium bromide Catalog Numbers: AC199870000, AC199871000, AC199875000, AC212530000, AC212530250, L117-500 Synonyms; Lithium monobromide Fisher Scientific Company Identification One Reagent Lane Pair Lawn, NJ.07410 For information in the US, call: 201-796-7100 Emergency Number US: 201-796-7100 CHEMTREC Phone Number, US: 800-424-9300 Section 2 - Composition, Information on Ingredients CASE: 7550-35-8 Chemical Name: Lithium bromide %: 99, EINECS#: 231-439-8 Hazard Symbols: XN Risk Phrases: 2 Section 3 - Hazards Identification EMERGENCY OVERVIEW Warning! Hygroscopic (absorbs moisture from the air). Harmful if'swallowed. May cause Kidney damage. May cause central nervous system effects. May cause cardiac disturbances. May cause eye, skin, and respiratory rat ivtaion. Target Organs: Blood, kidneys, central nervous system, cardiovascular system, Potential Health Effects Eye: May cause eye invitation. Exposure to bromides may cause rashes, especially of the face (resembling aene) and boils. Anhydrous lithium Skin: bromide is extremely hygroscopic and contact with tissue can produce a dehydrating action resulting in localized bums. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system depression, characterized by excitement, followed by headache, dizziness, drowsiness, and nausea. Advanced Ingestion: S885 may cause collapse, unconsciousness, coma and possible death due to respiratory failure, May cause 'BeSHON disturbed blood electrolyte balance. Large doses of lithium may cause dizziness, prostration, and kidney damage Dehydration, weigh loss, slurred speech, blurred vision, sensory loss, ataxia (failure of muscular coordination), tremors, and convulsions may occur. Inhalation: May cause severe ititation ofthe upper respiratory tract with pain, burns, and inflammation Chronic ingestion may cause dizziness, ringing in the ears, visual disturbances, tremors, and mental confusion. Chronic: Profonged absorption may affect electroite balance and impair kidney function. Dehydration, weight loss, skin effects, and thyroid disturbances have been reported. Chronic exposure may cause kidney damage Seation 4 - First Aid MeasuresImmediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower Eyes eyelids, Get medical aid immediately. Get meal aid iametiately. Immediately flush skin with plenty of water fr at last 15 minutes while removing contaminated clothing and shoes Ingestion; P&M indice vomiting. 1 itm is conscious and alert, give 2-4 cpfuls of miko water. Get medical ad immediately Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is Inhalation: difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. I breathing has ceased apply artificial respiration using oxyyen and a suitable mechanical device such asa bag and a mask. Notes to Pryscians et symptomatcally and supporively. Section 5 - Fire Fighting Measures ae As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH Information; (@PProved or equivalent), and full protective gear, During. fie, ivtating and highly toxic gases may be generated by thermal decomposition or combustion. a ol ishing media most appropriate for the surrounding fire, Mele Use extinguishing media most appropriate forthe surrounding fi Autoignition ath Temperature NOt Ach Flash Point: Not applicable. Explosion Limits: Lower: Explosion Limits: Upper: NFPA Rating: health: 2; flammability: 0; instabiity: 1; Not available Not available Section 6 - Accidental Release Measures General, USE proper personal protective equipment as indicated in Section 8, ‘Vacuum oF sweep up material and place into a suitable disposal container, Cleanup spills immediately, SpillsLeaks: observing precautions inthe Protective Equipment section, Avoid generating dusty conditions. Provide ventilation, Section 7 - Handling and Storage Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate Handling: ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing, Keep container tightly closed. Avoid breathing dust Storage: Store ina coo, dry, well-ventilated atea away from incompatible substances, Store protected from moisture Section 8 - Exposure Controls, Personal Protection OSHA Vacated PELs: Lithium bromide: None listed Engineering Controls Facilites storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep abome concentrations low. Exposure Limits Personal Protective Equipment ‘Wear appropriate protective eyeglasses or chemical safety gougles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166, Skin: Wear appropriate protective gloves to prevent skin exposure, Clothing: Wear appropriate protective clothing to prevent skin exposure. A respiratory protection program that meets OSHA's 29 CFR 1910,134 and ANSI 288.2 requirements or Byes:Respirators: European Standard EN 149 must be followed whenever workplace conditions warrant respirator use, Section 9 - Physical and Chemical Properties Physical State: Calor: Odor: pH: Vapor Pressure: ‘Vapor Density Evaporation Rate: Viscosity Boiling Point: Freezing/Melting Point Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: Molecular Weight: Powder white none reported ‘Neutral/Alkaline Not available Not available Not applicable. Not applicable, 1265 deg C (2,309.00°F) 547 deg C(1,016.60°F) Not available Soluble 3.46 LiBr 86.85 Section 10 - Stability and Reactivity Chemical Stability: Conditions to Avoid Hygroscopic: absorbs moisture or water from the ai Dust generation, moisture, excess het. Incompatibilities with Other Materials Strong acids, Hazardous Decomposition Products Hydrogen bromide, oxides of lithium, Hazardous Polymerization Will nat oceur. Section 11 - Toxicological Information RTECS#: CAS# 7550-35-8: 015755000 RTECS: CAS# 7550-35-8: Oral, mouse: LDSO= Lpsoicso; Oral, mouse: LDS0 = 2353 mgkkg; Oral, rat: LDSO = 1800 mg/kg: Other: Ora, at: LDSO = 1800 Carcinogenicity: Other: No information found. 1840 mgkg; Lithium bromide ~ Not listed asa carcinogen by ACGIH, IARC, NTP, of CA Prop 65. Section 12 - Ecological Information Not available Section 13 ~ Disposal Considerations Dispose of in a manner consistent with federal, state, and local regulations, Section 14 - Transport Information us Dor Shipping Name: Not Regulated Hazard Class: UN Number: Packing Group: Canada TDG: Shipping Name: Not regulated as a hazardous material Hazard Class: UN Number: Packing Group: Section 15 - Regulatory InformationEuropean/International Regutations European Labeling in Accordance with EC Directives Hazard Symbols: XN Risk Phrases: R22 Harmful if swallowed. Safety Phrases: WGK (Water Danger/Protection) CAS# 7550-35-8: 1 Canada CAS# 7550-35-8 is listed on Canada's DSL List Canadian WHMIS Classifications: D2B This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all ofthe information required by those regulations (CAS# 7550-35-8 is not listed on Canada’s Ingredient Disclosure List. US Federal TSCA CAS# 7550-35 Inventory, is listed on the TSCA REVIEWED Section 16 - Other Information MSDS Creation Date: 6/29/1999 DATE; Meg 28 2012. Revision #6 Date 7/20/2009 hike fs The information above is believed to be accurate and represents the best information currently available fous. However, we make no watranty of merchantibility or any other warranty, express or implied with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability ofthe information for their particular purposes. In no event shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential, or exemplary damages howsoever arising, even if the company has been advised of the possibility of such damages.